N-Acetyl Selank

N-Acetyl Selank is an acetylated Selank analog. PubChem catalogs the molecule, but direct human clinical literature for the modified form is notably sparse. The functional claims around it are largely extrapolated from the parent peptide Selank — a tuftsin-derived heptapeptide studied in Russian anxiety-related literature.

For the modified analog, the main mechanistic argument is pharmacokinetic: N-terminal acetylation may increase resistance to enzymatic breakdown. The parent Selank literature suggests anxiolytic and stress-modulating effects through several pathways, including inhibition of enkephalin-degrading enzymes, cytokine modulation, and broader gene-expression effects relevant to GABA-related signaling. Human parent-peptide studies reported benefit in generalized anxiety disorder and neurasthenia, plus immunomodulatory cytokine shifts in anxiety-asthenic disorders.